okyopharma.com (OKYO) Year-over-year earnings per share growth for the last twelve months

OKYO Pharma Ltd (OKYO) - corporate logo

OKYO Pharma Limited (OKYO) aims to develop high-margin dry eye treatments with a sustained demand cycle. However, geopolitical tensions and logistical collapses are hindering the execution of global trials. The company's financial stability relies solely on external investments in the absence of its own cash flow. The quarterly EPS change illustrates these imbalances, with the parameter reaching -114.80, signaling the current profit dynamics.

OKYO Pharma (OKYO) Earnings per share growth in annualized terms for the last twelve months: for the period 06/27/2023 - 11/18/2026

Analytical breakdowns for OKYO Pharma Limited

- share price and expert price forecast:
Comprehensive company analysis:okyopharma.com, OKYO
Finished products of okyopharma.com

This indicator measures the rate of change in earnings per share (EPS) on a quarterly basis, allowing analysts to filter out management optimism and identify real market demand through yield dynamics. Analyzing quarterly EPS growth helps assess the extent to which the financial success of OKYO Pharma Limited (OKYO) is supported by the efficiency of small research teams developing innovative treatments for dry eye syndrome.

Who OKYO Pharma Limited competes with

Alcon Corp (ALC) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Bausch Health (BLCO)|Year-over-year earnings per share growth for the last twelve months glaukos.com|Apellis Pharmaceuticals (APLS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth BLTE|OCUL - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth HROW (Harrow Inc)|Year-over-year net earnings per share change for the last twelve months Viridian Corp (VRDN)|LENZ - Year-over-year earnings per share growth for the last twelve months|Oculis - Year-over-year earnings per share growth rate for the last twelve months|EyePoint Pharmaceuticals (EYPT) - Year-over-year earnings per share growth for the last twelve months|Kodiak Sciences Inc (KOD) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months ALDX|KALA: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth IRD|Quarterly EPS earnings growth Adverum Biotechnologies Inc. (ADVM)|Year-over-year earnings per share growth for the last twelve months outlooktherapeutics.com OTLK|Year-over-year net earnings per share change for the last twelve months Clearside Biomedical, Inc. (CLSD)|NBY - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months KPRX (kiorapharma.com)|Alimera Sciences (ALIM) - Year-over-year earnings per share growth for the last twelve months|Eyenovia Inc. - Year-over-year earnings per one share growth for the last 12 months|GHSI (Guardion Health Sciences) - Quarterly EPS earnings growth|Ocuphire Pharma - Year-over-year net earnings per share trend for the last twelve months|Year-over-year net earnings per share growth for the last 12 months OPT (Opthea)